SCHEMBL23663266

SCHEMBL23663266

COc1ccc(Oc2c(Cl)cc(Br)cc2Cl)cc1[SH](=O)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 10/20 0.42
▸ RORC P51449 5/20 0.42
▸ NPBWR1 P48145 4/20 0.39
▸ MCHR1 Q99705 2/20 0.39
▸ THRA P10827 6/20 0.38
▸ PGR P06401 1/20 0.34
▸ HTR2A P28223 1/20 0.33
▸ SLC6A4 P31645 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ TUBB4A P04350 1/20 0.33
▸ TUBB P07437 1/20 0.33
▸ TUBA3C P0DPH7 1/20 0.33
▸ TUBA1B P68363 1/20 0.33
▸ TUBA4A P68366 1/20 0.33
▸ TUBB4B P68371 1/20 0.33
▸ TUBB3 Q13509 1/20 0.33
▸ TUBB2A Q13885 1/20 0.33
▸ TUBB8 Q3ZCM7 1/20 0.33
▸ TUBA3E Q6PEY2 1/20 0.33
▸ TUBA1A Q71U36 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26414144 0.84 CCR5 (0.39) THRBRORCNPBWR1MCHR1THRA
SCHEMBL26401671 0.83 THRA (0.36) THRBNPBWR1MCHR1THRAALDH1A1
SCHEMBL26401675 0.80 THRB (0.48) THRBTHRA
SCHEMBL23663148 0.80 THRB (0.46) THRBRORCNPBWR1MCHR1THRA
SCHEMBL23663084 0.78 POLB (0.52) THRBRORCTHRAALDH1A1
SCHEMBL29965211 0.78 POLB (0.52) THRBRORCTHRAALDH1A1
SCHEMBL29965444 0.78 TUBB1 (0.48) THRBRORCTHRATUBB1ALDH1A1
SCHEMBL23663122 0.78 TUBB1 (0.48) THRBRORCTHRATUBB1ALDH1A1
SCHEMBL29965390 0.77 TRPV4 (0.43) THRBRORCTHRAPGRALDH1A1
SCHEMBL23663112 0.77 TRPV4 (0.43) THRBRORCTHRAPGRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780825-B2 Thyroid hormone receptor agonists and use thereof ECCOGENE (SHANGHAI) CO., LTD. (CN) 2023-10-10 — — US disclosed
US-11780825-B2 Thyroid hormone receptor agonists and use thereof ECCOGENE (SHANGHAI) CO., LTD. (CN) 2023-10-10 — — US disclosed
WO-2021143706-A1 SUBSTITUTED TRIAZINONES AS THYROID HORMONE RECEPTOR AGONISTS ECCOGENE (SHANGHAI) CO., LTD. (CN) 2021-07-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11780825-B2 Thyroid hormone receptor agonists and use thereof TSHR, THRA, THRB THRB 3/4885RORC 187/4885NPBWR1 154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback